Stocktoria
Avalo Therapeutics, Inc. AVTX
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2015-11-13
Avalo Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| Point72 Asset Management, L.P. | 916,142 | $13.7M | 4.95% |
| MILLENNIUM MANAGEMENT LLC | 835,484 | $12.5M | 4.51% |
| CITADEL ADVISORS LLC | 260,535 | $3.9M | 1.41% |
| RENAISSANCE TECHNOLOGIES LLC | 120,114 | $1.8M | 0.65% |
| TWO SIGMA INVESTMENTS, LP | 64,425 | $961,865 | 0.35% |
| BlackRock Finance, Inc. | 329 | $4,103 | — |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.